Xanthine oxidase activity in the dexamethasone-induced hypertensive rat

Microvascular Research

Volumn 66, Issue 1, 2003, Pages 30-37

  Wallwork, Camille J ^a   Parks, Dale A ^b   Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Glucocorticoids; Hypertension; Microcirculation; Organ injury mechanism; Oxygen free radicals; Skeletal muscle

Indexed keywords

ALLOPURINOL; DEXAMETHASONE; DRINKING WATER; XANTHINE DEHYDROGENASE; XANTHINE OXIDASE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; DOSE CALCULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; GENERAL ANESTHESIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT STRAIN;

RATTUS NORVEGICUS;

EID: 0038460798     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-2862(03)00019-0     Document Type: Article

References (59)

1. Aoki K., Tankaw H., Fujinami, T. Pathological studies on the endocrine organs of the spontaneously hypertensive rat. Jpm. Heart J. 4:1963;426-442.
2. Brem A.S. Insights into glucocorticoid-associated hypertension. Am. J. Kidney Dis. 37:2001;1-10.
3. De Lano F.A., Zweifach B.W. Anesthesia and microvascular dynamics in spontaneously hypertensive rats. Am. J. Physiol. 241:1981;H821-H828.
4. Fridovich I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J. Biol. Chem. 245:1970;4053-4057.
5. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q.T., Taylor W.R., Harrison D.G., de L.H., Wilcox J.N., Griendling K.K. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80:1997;45-51.
6. Grunfeld S., Hamilton C.A., Mesaros S., McClain S.W., Dominiczak A.F., Bohr D.F., Malinski T. Role of superoxide in the depressed nitric oxide production by endothelial cells from genetically hypertensive rats. Hypertension. 26:1995;854-857.
7. Handa M., Kondo K., Suzuki H., Saruta T. Dexamethasone hypertension in rats: role of prostaglandins and pressor sensitivity to norepinephrine. Hypertension. 6:1984;236-241.
8. Heitzer T., Wenzel U., Hink U., Krollner D., Skatchkov M., Stahl R.A., MacHarzina R., Bräsen J.H., Meinertz T., Münzel T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 55:1999;252-260.
9. Higuchi Y., Ono K., Sekita S., Onodera H., Mitsumori K., Nara Y., Satake M. Preventive effects of Shichimotsu-koka-to on renal lesions in stroke-prone spontaneously hypertensive rats. Biol. Pharm. Bull. 21:1998;914-918.
10. Hutchins P.M., Darnell A.E. Observation of a decreased number of small arterioles in spontaneously hypertensive rats. Circ. Res. 34-35:(Suppl I):1974;161-165.
11. Kanno K., Hirata Y., Imai T., Iwashina M., Marumo F. Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am. J. Physiol. 267:1994;H2318-H2324.
12. Kenyon C.J., Panarelli M., Holloway C.D., Dunlop D., Morton J.J., Connell J.M., Fraser R. The role of glucocorticoid activity in the inheritance of hypertension: studies in the rat. J. Steroid Biochem. Mol. Biol. 45:1993;7-11.
13. Kerr S., Brosnan M.J., McIntyre M., Reid J.L., Dominiczak A.F., Hamilton C.A. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension. 33:1999;1353-1358.
14. Kim C.Y., Imai Y., Itoi K., Hashimoto J., Nobunaga T., Satoh H., Abe K. Analysis of circadian variation of blood pressure and heart rate in dexamethasone-induced hypertensive rats. Clin. Exp. Hypertens. 18:1996;65-76.
15. Klein A.S., Joh J.W., Rangan U., Wang D., Bulkley G.B. Allopurinol: discrimination of antioxidant from enzyme inhibitory activities. Free Radic. Biol. Med. 21:1996;713-717.
16. Konagaya M., Bernard P.A., Max S.R. Blockade of glucocorticoid receptor binding and inhibition of dexamethasone-induced muscle atrophy in the rat by RU38486, a potent glucocorticoid antagonist. Endocrinology. 119:1986;375-380.
17. Kumar K.V., Das U.N. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic. Res. Commun. 19:1993;59-66.
18. Laakso J., Mervaala E., Himberg J.J., Teravainen T.L., Karppanen H., Vapaatalo H., Lapatto R. Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension. Hypertension. 32:1998;902-906.
19. Lacy F., Gough D.A., Schmid-Schönbein G.W. Role of xanthine oxidase in hydrogen peroxide production. Free Radic. Biol. Med. 25:1998;720-727.
20. Lacy F., O'Connor D.T., Schmid-Schönbein G.W. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J. Hypertens. 16:1998;291-303.
21. Li M., Fraser T., Wang J., Whitworth J.A. Dexamethasone-induced hypertension in the rat: effects of L-arginine. Clin. Exp. Pharmacol. Physiol. 24:1997;730-732.
22. Lim H.H., DeLano F.A., Schmid-Schönbein G.W. Life and cell death labeling in the microcirculation of the spontaneously hypertensive rat. J. Vasc. Res. 38:2001;228-236.
23. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312:1985;159-163.
24. McIntyre M., Bohr D.F., Dominiczak A.F. Endothelial function in hypertension: the role of superoxide anion. Hypertension. 34:1999;539-545.
25. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA. 88:1991;10045-10048.
26. Newaz M.A., Adeeb N.N., Muslim N., Razak T.A., Htut N.N. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clin. Exp. Hypertens. 18:1996;1035-1050.
27. Newaz M.A., Nawal N.N. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am. J. Hypertens. 11:1998;1480-1485.
28. Nielsen V.G., Weinbroum A., Tan S., Samuelson P.N., Gelman S., Parks D.A. Xanthine oxidoreductase release after descending thoracic aorta occlusion and reperfusion in rabbits. J. Thorac Cardiovasc. Surg. 107:1994;1222-1227.
29. Parks D.A., Williams T.K., Beckman J.S. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am. J. Physiol. 254:1988;G768-G774.
30. Pfeffer K.D., Huecksteadt T.P., Hoidal J.R. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J. Immunol. 153:1994;1789-1797.
31. Planey S.L., Litwack G. Glucocorticoid-induced apoptosis in lymphocytes. Biochem. Biophys. Res. Commun. 279:2000;307-312.
32. Qiu C., Baylis C. Dexamethasone worsens nitric oxide inhibition-induced hypertension and renal dysfunction. Am. J. Hypertens. 13:2000;1097-1102.
33. Rajashree S., Puvanakrishnan R. Dexamethasone induced alterations in enzymatic and nonenzymatic antioxidant status in heart and kidney of rats. Mol. Cell. Biochem. 181:1998;77-85.
34. Ruch W., Baumann J.B., Häusler A., Otten U.H., Siegl H., Girard J. Importance of the adrenal cortex for development and maintenance of hypertension in spontaneously hypertensive rats. Acta Endocrinol. (Copenh.). 105:1984;417-424.
35. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens. Res. 19:1996;1-8.
36. Sato A., Suzuki H., Nakazato Y., Shibata H., Inagami T., Saruta T. Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension. J. Hypertens. 12:1994;511-516.
37. Schimmer B.P., Parker K.L. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 1996;1459-1485 McGraw-Hill, New York.
38. Schmid-Schönbein G.W., Seiffge D., DeLano F.A., Shen K., Zweifach B.W. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats [see comments]. Hypertension. 17:1991;323-330.
39. Schnackenberg C.G., Welch W.J., Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic role of nitric oxide . Hypertension. 32:1998;59-64.
40. Schoutsen B., de Jong J.W. Age-dependent increase in xanthine oxidoreductase differs in various heart cell types. Circ. Res. 61:1987;604-607.
41. Sholter D.E., Armstrong P.W. Adverse effects of corticosteroids on the cardiovascular system. Can. J. Cardiol. 16:2000;505-511.
42. Suzuki H., DeLano F.A., Parks D.A., Jamshidi N., Granger D.N., Ishii H., Suematsu M., Zweifach B.W., Schmid-Schönbein G.W. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. USA. 95:1998;4754-4759.
43. Suzuki H., Handa M., Kondo K., Saruta T. Role of renin-angiotensin system in glucocorticoid hypertension in rats. Am. J. Physiol. 243:1982;E48-E51.
44. Suzuki H., Schmid-Schönbein G.W., Suematsu M., DeLano F.A., Forrest M.J., Miyasaka M., Zweifach B.W. Impaired leukocyte-endothelial cell interaction in spontaneously hypertensive rats. Hypertension. 24:1994;719-727.
45. Suzuki H., Swei A., Zweifach B.W., Schmid-Schönbein G.W. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography. Hypertension. 25:1995;1083-1089.
46. Suzuki H., Zweifach B.W., Forrest M.J., Schmid-Schönbein G.W. Modification of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids. J. Leukoc. Biol. 57:1995;20-26.
47. Suzuki H., Zweifach B.W., Schmid-Schönbein G.W. Dependence of elevated mesenteric arteriolar tone on glucocorticoids in spontaneously hypertensive rats. Int. J. Microcirc. Clin. Exp. 15:1995;309-315.
48. Swei A., Lacy F., DeLano F.A., Schmid-Schönbein G.W. Oxidative stress in the Dahl hypertensive rat. Hypertension. 30:1997;1628-1633.
49. Tailor A., Flower R.J., Perretti M. Dexamethasone inhibits leukocyte emigration in rat mesenteric post-capillary venules: an intravital microscopy study. J. Leukoc. Biol. 62:1997;301-308.
50. Tailor A., Tomlinson A., Salas A., Panés J., Granger D.N., Flower R.J., Perretti M. Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut. 45:1999;705-712.
51. Trachtman H., Valderrama E., Futterweit S. Nephrotoxicity of allopurinol is enhanced in experimental hypertension. Hypertension. 17:1991;194-202.
52. Tschudi M.R., Mesaros S., Luscher T.F., Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension. 27:1996;32-35.
53. Valentine J.F., Nick H.S. Glucocorticoids repress basal and stimulated manganese superoxide dismutase levels in rat intestinal epithelial cells. Gastroenterology. 107:1994;1662-1670.
54. Vega G.W., Rosón M.I., Bellver A., Celentano M.M., de la Riva I.J. Nitric oxide and superoxide anions in vascular reactivity of renovascular hypertensive rats. Clin. Exp. Hypertens. 17:1995;817-835.
55. Vogt C.J., Schmid-Schönbein G.W. Microvascular endothelial cell death and rarefaction in the glucocorticoid-induced hypertensive rat. Microcirculation. 8:2001;129-139.
56. Walker B.R., Best R., Shackleton C.H., Padfield P.L., Edwards C.R. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension. 27:1996;190-196.
57. Watts R.W., Watts J.E., Seegmiller J.E. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J. Lab. Clin. Med. 66:1965;688-697.
58. Wu C.H., Chi J.C., Jerng J.S., Lin S.J., Jan K.M., Wang D.L., Chien S. Transendothelial macromolecular transport in the aorta of spontaneously hypertensive rats. Hypertension. 16:1990;154-161.
59. Zweifach B.W., Kovalcheck S., DeLano F.A., Chen P. Micropressure-flow relationship in a skeletal muscle of spontaneously hypertensive rats. Hypertension. 3:1981;601-614.